U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06896448) titled 'Innovative OSA Screening in Head and Neck Cancer Patients with the Apneal App' on March 10.
Brief Summary: Obstructive sleep apnea syndrome is a common but often underdiagnosed condition, with significant impacts on quality of life, such as fatigue, attention disorders, and an increased risk of heart attack or stroke. Structural changes in the head and neck region appear to contribute to the onset or worsening of this condition.
To improve patients' quality of life, early diagnosis is essential. Currently, diagnosis relies on expensive devices, often associated with long waiting times. To address these challenges, an innovative so...